Advertisement
Screener

Minerva Neurosciences, Inc. (NERV) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Minerva Neurosciences, Inc. Basic Shares Outstanding (Weighted Average)

Minerva Neurosciences, Inc. (NERV) reported Basic Shares Outstanding (Weighted Average) of 46.60 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07

  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 46.60M shares, a 515.66% increase year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 43.90M shares, a 480.00% increase year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.15M shares, a 47.28% increase year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.57M shares, a 0.00% change year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 8.46M shares, a 11.82% increase from fiscal 2024.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 7.57M shares, a 16.33% increase from fiscal 2023.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 6.51M shares, a 21.84% increase from fiscal 2022.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 5.34M shares, a 0.00% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-3046.60M shares
10-Q · filed 2026-08-07
45.26M shares
10-Q · filed 2026-08-07
33.88M shares
derived: average of 3 quarters · filed 2026-08-07
27.30M shares
derived: average of 4 quarters · filed 2026-08-07
2026-03-3143.90M shares
10-Q · filed 2026-05-05
27.52M shares
derived: average of 2 quarters · filed 2026-05-05
20.87M shares
derived: average of 3 quarters · filed 2026-05-05
17.55M shares
derived: average of 4 quarters · filed 2026-08-07
2025-12-3111.15M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
9.36M shares
derived: average of 2 quarters · filed 2026-03-11
8.76M shares
derived: average of 3 quarters · filed 2026-08-07
8.46M shares
10-K · filed 2026-03-11
2025-09-307.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 2 quarters · filed 2026-08-07
7.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 4 quarters · filed 2026-08-07
2025-06-307.57M shares
10-Q · filed 2026-08-07
7.57M shares
10-Q · filed 2026-08-07
7.57M shares
derived: average of 3 quarters · filed 2026-08-07
7.57M shares
derived: average of 4 quarters · filed 2026-08-07
2025-03-317.57M shares
10-Q · filed 2026-05-05
7.57M shares
derived: average of 2 quarters · filed 2026-05-05
7.57M shares
derived: average of 3 quarters · filed 2026-05-05
7.57M shares
derived: average of 4 quarters · filed 2026-05-05
2024-12-317.57M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
7.57M shares
derived: average of 2 quarters · filed 2026-03-11
7.57M shares
derived: average of 3 quarters · filed 2026-03-11
7.57M shares
10-K · filed 2026-03-11
2024-09-307.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 2 quarters · filed 2025-11-05
7.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 4 quarters · filed 2025-11-05
2024-06-307.57M shares
10-Q · filed 2025-08-14
7.57M shares
10-Q · filed 2025-08-14
7.57M shares
derived: average of 3 quarters · filed 2025-08-14
7.57M shares
derived: average of 4 quarters · filed 2025-08-14
2024-03-317.57M shares
10-Q · filed 2025-05-13
7.57M shares
derived: average of 2 quarters · filed 2025-05-13
7.57M shares
derived: average of 3 quarters · filed 2025-05-13
7.06M shares
derived: average of 4 quarters · filed 2025-05-13
2023-12-317.58M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
7.57M shares
derived: average of 2 quarters · filed 2025-02-25
6.89M shares
derived: average of 3 quarters · filed 2025-02-25
6.51M shares
10-K · filed 2025-02-25
2023-09-307.57M shares
10-Q · filed 2024-11-05
6.54M shares
derived: average of 2 quarters · filed 2024-11-05
6.15M shares
10-Q · filed 2024-11-05
5.94M shares
derived: average of 4 quarters · filed 2024-11-05
2023-06-305.51M shares
10-Q · filed 2024-08-06
5.43M shares
10-Q · filed 2024-08-06
5.40M shares
derived: average of 3 quarters · filed 2024-08-06
5.38M shares
derived: average of 4 quarters · filed 2024-08-06
2023-03-315.34M shares
10-Q · filed 2024-05-01
5.34M shares
derived: average of 2 quarters · filed 2024-05-01
5.34M shares
derived: average of 3 quarters · filed 2024-05-01
5.34M shares
derived: average of 4 quarters · filed 2024-05-01
2022-12-315.34M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
5.34M shares
derived: average of 2 quarters · filed 2024-02-22
5.34M shares
derived: average of 3 quarters · filed 2024-02-22
5.34M shares
10-K · filed 2024-02-22
2022-09-305.34M shares
10-Q · filed 2023-11-07
5.34M shares
derived: average of 2 quarters · filed 2023-11-07
5.34M shares
10-Q · filed 2023-11-07
5.34M shares
derived: average of 4 quarters · filed 2023-11-07
2022-06-305.34M shares
10-Q · filed 2023-08-01
5.34M shares
10-Q · filed 2023-08-01
5.34M shares
derived: average of 3 quarters · filed 2023-08-01
5.34M shares
derived: average of 4 quarters · filed 2023-08-01
2022-03-315.34M shares
10-Q · filed 2023-05-15
5.34M shares
derived: average of 2 quarters · filed 2023-05-15
5.34M shares
derived: average of 3 quarters · filed 2023-05-15
14.69M shares
derived: average of 4 quarters · filed 2023-05-15
2021-12-315.34M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
5.34M shares
derived: average of 2 quarters · filed 2023-03-08
17.80M shares
derived: average of 3 quarters · filed 2023-03-08
5.34M shares
10-K · filed 2023-03-08
42.72M shares
10-K · filed 2022-03-01
2021-09-305.34M shares
10-Q · filed 2022-11-09
42.72M shares
10-Q · filed 2021-11-08
24.03M shares
derived: average of 2 quarters · filed 2022-11-09
5.34M shares
10-Q · filed 2022-11-09
42.72M shares
10-Q · filed 2021-11-08
2021-06-3042.72M shares
10-Q · filed 2021-08-02
42.72M shares
10-Q · filed 2021-08-02
2020-12-3142.70M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
42.31M shares
derived: average of 2 quarters · filed 2022-03-01
41.37M shares
derived: average of 3 quarters · filed 2022-03-01
40.82M shares
10-K · filed 2022-03-01
2020-09-3041.92M shares
10-Q · filed 2021-11-08
40.70M shares
derived: average of 2 quarters · filed 2021-11-08
40.20M shares
10-Q · filed 2021-11-08
2020-06-3039.48M shares
10-Q · filed 2021-08-02
39.33M shares
10-Q · filed 2021-08-02
2019-12-3139.04M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
39.03M shares
derived: average of 2 quarters · filed 2021-03-08
39.03M shares
derived: average of 3 quarters · filed 2021-03-08
39.01M shares
10-K · filed 2021-03-08
2019-09-3039.03M shares
10-Q · filed 2020-11-02
39.03M shares
derived: average of 2 quarters · filed 2020-11-02
39.01M shares
10-Q · filed 2020-11-02
2019-06-3039.03M shares
10-Q · filed 2020-08-03
39.00M shares
10-Q · filed 2020-08-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Annexon, Inc. (ANNX)United States$0.147B-4.22
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91